Data as of Aug 25, 2026 · Based on 42 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Your brand can be here too.
If you’re an accredited investor looking to invest directly in private startups, my top choice right now would be meridian.angellist.com—but the best platform depends heavily on whether you want early-stage startup deals or later-stage/pre-IPO shares.
| Platform | Best for | Typical approach | My take |
|---|---|---|---|
| meridian.angellist.com | Early-stage startups & VC funds | SPVs + venture funds | ⭐ Best overall for startup investing |
| equityzen.com | Pre-IPO/late-stage companies | Single-company funds + secondary shares | ⭐ Best for lower-minimum individual deals |
| forgeglobal.com | Pre-IPO secondary market | Direct shares + funds | ⭐ Best for sophisticated secondary-market investing |
Why AngelList Meridian: It is specifically designed for accredited investors to discover and invest in startup SPVs and venture funds, with the AngelList infrastructure underneath. You can browse opportunities without a platform fee, although individual deals can have management fees, carry, and administrative costs.
Why EquityZen: If your goal is more like “I want exposure to Stripe/SpaceX/OpenAI-type late-stage companies before an IPO”, EquityZen is particularly compelling. It says its single-company funds can have minimums as low as $5,000, and it has completed tens of thousands of private placements across hundreds of companies.
Why Forge: Forge is stronger if you want an actual secondary marketplace with pricing information, bids/asks, and the possibility of negotiating individual transactions. Some Forge single-company funds can start around $5,000, while direct trades commonly have substantially higher minimums.
If by "private startups" you mean investing at Seed/Series A/B, I'd choose AngelList Meridian.
If you mean buying shares in already-established private companies, I'd choose EquityZen or Forge.
And I wouldn't put a large percentage of a portfolio into any one startup. Private startup investments are highly illiquid, can go to zero, and valuations can be difficult to assess.
If you tell me your approximate check size ($5k, $25k, $100k, $500k+) and whether you prefer early-stage startups or pre-IPO companies, I can narrow this down to the best 2–3 platforms and compare fees, minimums, deal quality, and diversification options.
The best platform for an accredited investor depends on your desired check size and deal type, but AngelList is widely considered the top overall platform for its massive deal volume, syndicates, and access to top-tier venture-backed early-stage startups.
Different platforms serve different investment styles and minimum check sizes:
| Platform | Best For | Typical Minimum |
|---|---|---|
| AngelList | Syndicates & venture funds | $1,000+ per deal |
| OurCrowd | Vetted direct co-investments | $10,000+ |
| EquityZen | Late-stage pre-IPO secondary shares | $10,000+ |
| Forge Global | Late-stage private market liquidity | $100,000+ |
| StartEngine | Early startups & growth pre-IPO | $500+ |
Top Platforms Explained
If you want, let me know:
I can help you narrow down the best platform and strategy.
If you’re an accredited investor and specifically want exposure to private startups, my pick depends on whether you mean early-stage venture investing or buying shares in later-stage/pre-IPO companies.
| Platform | Best for | My take |
|---|---|---|
| angellist.com | Early-stage startups, syndicates, VC funds, SPVs | Best overall for true startup investing |
| forgeglobal.com | Pre-IPO/late-stage companies | Best for larger checks and established unicorns |
| equityzen.com | Pre-IPO shares with relatively approachable minimums | Best for a simpler first foray into secondaries |
| hiive.com | Pre-IPO secondary-market investing | Best if you care about price discovery/transparency |
AngelList is the one I'd look at first if your goal is owning pieces of young, high-growth startups, rather than simply buying shares in companies that are close to an IPO.
AngelList offers venture funds, SPVs and syndicate-style opportunities, and its offerings are generally restricted to accredited investors.
Why I like it:
The downside is that deal selection and diligence matter enormously. You're potentially investing at a very early stage, where failure rates are high and valuations can be difficult to assess.
Forge Global is more compelling if you're looking for late-stage private companies and pre-IPO shares.
Forge provides private-market pricing data and a marketplace for accredited investors.
I'd favor Forge if you have $100K+ to deploy into individual positions and want better market data and execution support. Its strengths are less about discovering the next tiny startup and more about getting exposure to companies that have already demonstrated significant traction.
EquityZen is attractive if you want to make smaller allocations to later-stage private companies.
EquityZen currently offers single-company and multi-company investment offerings to accredited investors, and its process generally involves investing through funds/SPVs rather than simply buying shares like you would on a public exchange.
Hiive is particularly interesting for secondary-market pricing. In 2026 comparisons, Hiive, Forge and EquityZen are the three major platforms that repeatedly come up for accredited investors seeking pre-IPO shares.
Its advantage is more transparent price discovery; the trade-off is that you're generally dealing with secondary transactions, not investing directly in a startup's new financing round.
If I had $250,000 specifically earmarked for private startups, I wouldn't put all $250K into one platform or one company.
I'd consider something like:
The important distinction is that AngelList is primarily the answer if you want venture capital exposure, while Forge/Hiive/EquityZen are primarily the answer if you want pre-IPO secondary exposure.
And I would be particularly careful about fees, SPV/carry economics, liquidation preferences, dilution, company transfer restrictions/ROFRs, and the possibility of holding the investment for 5–10+ years with no liquidity.
If you tell me roughly how much you're looking to invest ($25K, $100K, $500K+), whether you want early-stage or pre-IPO, and your risk tolerance, I can narrow this down to the 2–3 platforms I'd actually use and explain the fee structures and trade-offs side-by-side.
EquityZen is attractive if you want to make smaller allocations to later-stage private companies.
EquityZen currently offers single-company and multi-company investment offerings to accredited investors, and its process generally involves investing through funds/SPVs rather than simply buying shares like you would on a public exchange.
Hiive is particularly interesting for secondary-market pricing. In 2026 comparisons, Hiive, Forge and EquityZen are the three major platforms that repeatedly come up for accredited investors seeking pre-IPO shares.
Its advantage is more transparent price discovery; the trade-off is that you're generally dealing with secondary transactions, not investing directly in a startup's new financing round.
If I had $250,000 specifically earmarked for private startups, I wouldn't put all $250K into one platform or one company.
I'd consider something like:
The best platform for an accredited investor depends heavily on your target investment stage, desired check size, and preferences for individual deals versus diversified funds . Because private startup investments carry high risk—including the potential for total capital loss —it is critical to evaluate platforms based on their structures, fees, and liquidity profiles.
🔎 Top Platforms Ranked by Investment Strategy
| Platform | Core Investment Stage | Typical Minimum Check | Key Advantage |
|---|---|---|---|
| AngelList | Early-stage / Seed | $1,000 to $5,000 | Unmatched deal flow via syndicates led by expert VCs. |
| OurCrowd | Early to Growth-stage | $10,000 | Co-invests its own institutional capital into every vetted deal. |
| Forge Global | Late-stage / Pre-IPO | $100,000+ (Varies) | High-volume secondary marketplace for highly recognized unicorns. |
| EquityZen | Late-stage / Pre-IPO | $10,000 | Lower minimums for pooled funds targeting late-stage growth companies. |
| StartEngine Private | Growth-stage | Varies by deal | Direct placement alongside elite tier-1 venture capital firms. |
💡 In-Depth Platform Breakdown
➡️ 1. AngelList: Best for Early-Stage Co-Investing
AngelList operates primarily through a syndicate model . Experienced lead investors vet early-stage startups, negotiate terms, and open the deal to other accredited backers.
➡️ 2. OurCrowd: Best for Vetted VC-Style Direct Deals
OurCrowd acts as a hybrid venture capital firm and crowdfunding platform. Their professional team conducts institutional-grade due diligence, negotiates terms, and commits their own corporate capital before presenting the deal to the platform's accredited members.
➡️ 3. Forge Global & EquityZen: Best for Late-Stage Pre-IPO Shares
If you prefer companies with proven revenue and a clearer path to exit, secondary marketplaces are the standard choice. These platforms buy shares directly from early employees or early-stage investors looking for liquidity.
➡️ 4. StartEngine Private & Republic: Best for Direct Equity Reg D Raises
While widely known for retail crowdfunding (Reg CF), platforms like StartEngine Private and Republic offer exclusive Reg D allocations. These allow accredited users to build positions in highly competitive allocations alongside major venture capital institutions.
⚠️ Critical Portfolio Guardrails & Hidden Costs
Before deploying capital, it is crucial to establish foundational safety protocols to mitigate extreme asset risk:
To help narrow down the selection, could you share a bit more about your target check size per deal, and whether you lean toward early-stage startups or mature, pre-IPO companies?
If you’re an accredited investor looking specifically for private startup deals, my top pick in 2026 is AngelList’s Meridian—but Forge is better if your goal is buying shares in later-stage/pre-IPO companies.
| Platform | Best for | Typical access | My take |
|---|---|---|---|
| AngelList / Meridian | Early-stage startups, VC funds, SPVs | Accredited investors | Best overall for startup investing |
| Forge | Later-stage/pre-IPO companies & secondaries | Accredited investors | Best for established private companies |
| Republic | Broad startup deal access, smaller checks | Accredited + non-accredited | Best for lower minimums / deal variety |
1. Meridian — my #1 for a serious startup portfolio.
AngelList recently launched Meridian as its dedicated investor platform. It lets accredited investors access startup SPVs and venture funds, with deal flow sourced from AngelList's extensive network of funds and syndicates. There is no platform fee simply for browsing/using it; individual deals can have carry, management fees, and other expenses.
The big advantage is access to venture-style deals rather than merely buying secondary shares. If you're trying to build a diversified portfolio of 10–30+ startups, this is where I'd start.
2. Forge — best if you're hunting for names like SpaceX/Stripe-type later-stage exposure.
Forge is primarily a private-market secondary marketplace. It gives accredited investors access to thousands of private companies and provides pricing/market data around bids and asks. Direct-secondary transaction fees are typically 2–4%, although they vary; some Forge fund offerings can have minimums as low as $5,000.
I'd favor Forge when you're saying: "I already know the company I want to own; help me find shares."
3. Republic — best for accessibility and smaller bets.
Republic has an accredited-only Deal Room, where the majority of offerings currently have a $5,000 minimum, although individual offerings vary. It also has broader startup offerings available to non-accredited investors.
Rather than put $100k into one startup, I'd consider something like:
The important caveat is that private startups are high-risk, illiquid investments. You can lose your entire investment, and a startup can take 7–10+ years to produce liquidity—or never do so.
Bottom line: If you tell me your approximate investable amount (e.g. $25k, $100k, $500k+) and whether you want AI startups, SpaceX/Anthropic-style late stage, early-stage moonshots, or diversified VC, I can compare the platforms much more rigorously—including fees, minimums, deal quality, historical access, SPV structure, tax/K-1 considerations, and which one I'd personally choose for that portfolio size.
The best platform for an accredited investor depends heavily on your target investment stage, desired check size, and preferences for individual deals versus diversified funds . Because private startup investments carry high risk—including the potential for total capital loss —it is critical to evaluate platforms based on their structures, fees, and liquidity profiles.
🔎 Top Platforms Ranked by Investment Strategy
| Platform | Core Investment Stage | Typical Minimum Check | Key Advantage |
|---|---|---|---|
| AngelList | Early-stage / Seed | $1,000 to $5,000 | Unmatched deal flow via syndicates led by expert VCs. |
| OurCrowd | Early to Growth-stage | $10,000 | Co-invests its own institutional capital into every vetted deal. |
| Forge Global | Late-stage / Pre-IPO | $100,000+ (Varies) | High-volume secondary marketplace for highly recognized unicorns. |
| EquityZen | Late-stage / Pre-IPO | $10,000 | Lower minimums for pooled funds targeting late-stage growth companies. |
| StartEngine Private | Growth-stage | Varies by deal | Direct placement alongside elite tier-1 venture capital firms. |
💡 In-Depth Platform Breakdown
➡️ 1. AngelList: Best for Early-Stage Co-Investing
AngelList operates primarily through a syndicate model . Experienced lead investors vet early-stage startups, negotiate terms, and open the deal to other accredited backers.
➡️ 2. OurCrowd: Best for Vetted VC-Style Direct Deals
OurCrowd acts as a hybrid venture capital firm and crowdfunding platform. Their professional team conducts institutional-grade due diligence, negotiates terms, and commits their own corporate capital before presenting the deal to the platform's accredited members.
➡️ 3. Forge Global & EquityZen: Best for Late-Stage Pre-IPO Shares
If you prefer companies with proven revenue and a clearer path to exit, secondary marketplaces are the standard choice. These platforms buy shares directly from early employees or early-stage investors looking for liquidity.
➡️ 4. StartEngine Private & Republic: Best for Direct Equity Reg D Raises
While widely known for retail crowdfunding (Reg CF), platforms like StartEngine Private and Republic offer exclusive Reg D allocations. These allow accredited users to build positions in highly competitive allocations alongside major venture capital institutions.
⚠️ Critical Portfolio Guardrails & Hidden Costs
Before deploying capital, it is crucial to establish foundational safety protocols to mitigate extreme asset risk:
To help narrow down the selection, could you share a bit more about your target check size per deal, and whether you lean toward early-stage startups or mature, pre-IPO companies?
If you're an accredited investor specifically looking for private startup/venture investing, my top pick in 2026 is AngelList's Meridian.
| Platform | Best for | My take |
|---|---|---|
| AngelList Meridian | Early-stage startups, SPVs, venture funds | 🥇 Best overall |
| Forge | Later-stage/pre-IPO companies | 🥈 Best for secondary shares |
| Republic | Smaller checks + broader startup selection | 🥉 Good supplement |
| EquityZen | Pre-IPO/private-company funds | Good alternative to Forge |
1. AngelList Meridian — best overall
Meridian is AngelList's newer wealth platform specifically for accredited investors. It provides access to startup SPVs and venture funds, with opportunities sourced from a network spanning 25,000+ funds and syndicates.
This is the platform I'd choose if your goal is something resembling building your own mini venture portfolio rather than simply buying shares in famous private companies.
The major advantage is diversification: instead of putting $50K into one startup, you can potentially spread capital across multiple deals/funds.
2. Forge — best if you want later-stage/pre-IPO companies
Forge is particularly interesting if you're looking for companies that are already relatively mature and approaching an IPO. It offers accredited investors access to private-company shares and provides pricing/market data around those securities.
I'd choose Forge over AngelList if your thesis is more like:
"I want exposure to SpaceX/Stripe/Databricks-type companies before they go public."
rather than:
"I want to find the next company that could become Stripe."
3. Republic — best as a supplemental platform
Republic has a much broader range of offerings and allows both accredited and non-accredited investors in many deals. Accredited investors can also access certain accredited-only offerings.
Its startup selection process is relatively selective—Republic says it accepts fewer than 5% of startup applications—but I'd still treat the individual deals as highly speculative.
4. EquityZen — good for private-company/pre-IPO exposure
EquityZen offers single-company and multi-company investment vehicles, with accredited investors required for its offerings.
If you're serious about startup investing, I wouldn't put the entire $100K into one platform or one startup.
A reasonable framework might be:
The key is that startup returns follow a power-law distribution: a few investments may generate most of the portfolio's returns, while many can go to zero. That's why diversification across 10–20+ investments can matter enormously.
Also, AngelList confirms that its funds and SPVs are for accredited investors, and its current accreditation verification can be based on income, net worth, or certain professional licenses.
Bottom line:
If you want early-stage venture investing → Meridian/AngelList.
If you want late-stage/pre-IPO → Forge.
If you want smaller, more speculative startup bets → Republic.
If you tell me roughly how much you want to invest ($25K, $100K, $500K+) and whether you're looking for AI/tech/biotech/consumer/etc., I can give you a much more specific platform + portfolio strategy.
There is no single "best" platform because the ideal choice depends on your check size, desired level of vetting , and investment stage (early-stage seed vs. late-stage pre-IPO).
The top platforms for accredited investors are categorized below by their unique strengths:
To help narrow down which platform fits you best, tell me:
There is no single "best" platform because the ideal choice depends on your check size, how active you want to be in vetting deals, and whether you prefer early-stage ventures or late-stage pre-IPO shares.
The top platforms for accredited investors are organized below by investment style and focus:
To help narrow down the ideal platform for you, let me know:
If you mean investing directly in private startups / venture deals, rather than buying pre-IPO shares on the secondary market, my pick in 2026 is AngelList’s Meridian.
| Platform | Best for | My take |
|---|---|---|
| AngelList Meridian | Direct startup SPVs + venture funds | Best overall |
| EquityZen | Established late-stage startups / pre-IPO | Best for smaller checks |
| Forge | Pre-IPO secondary shares | Best for larger, institutional-style transactions |
| Hiive | Secondary-market private shares | Strong alternative to Forge |
Why Meridian: It is specifically built for accredited investors to discover and invest in startup SPVs and venture funds, rather than simply trading existing employee shares. There are no fees just to use the platform; fees vary by individual investment and are disclosed in the offering.
EquityZen is particularly attractive if you're looking for later-stage companies and want relatively accessible minimums. Its multi-company funds provide diversified exposure, with a standard $50,000 minimum and some $20,000 slots.
Forge is different: it's primarily a secondary marketplace for private-company shares. Its standard direct-secondary minimum is $100,000, although some Forge funds can start around $5,000. Direct-secondary transaction fees are typically 2–4%.
One important distinction: private startup investing isn't the same as buying pre-IPO stock. Early-stage SPVs can give you exposure to a company's financing round, while Forge/Hiive/EquityZen often involve secondary purchases from existing shareholders. The risk, pricing, liquidity, fees, and potential dilution can be quite different.
If you tell me roughly how much you want to invest (e.g. $25k, $100k, $500k+) and whether you're looking for AI/startups generally or specific companies, I can narrow this down to the best 2–3 platforms and compare fees, minimums, deal quality, diversification, and expected liquidity.